Harbour Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $530K | Sell |
22,010
-450
| -2% | -$11.8K | 0.27% | 78 |
|
|
2026
Q1 | $631K | Sell |
22,460
-3,525
| -14% | -$93.8K | 0.34% | 70 |
|
|
2025
Q4 | $647K | Sell |
25,985
-4,840
| -16% | -$122K | 0.34% | 66 |
|
|
2025
Q3 | $785K | Sell |
30,825
-1,900
| -6% | -$46.9K | 0.34% | 62 |
|
|
2025
Q2 | $793K | Sell |
32,725
-525
| -2% | -$12.2K | 0.34% | 61 |
|
|
2025
Q1 | $843K | Sell |
33,250
-250
| -0.7% | -$6.54K | 0.38% | 58 |
|
|
2024
Q4 | $889K | Sell |
33,500
-1,450
| -4% | -$39.3K | 0.39% | 58 |
|
|
2024
Q3 | $1.01M | Buy |
34,950
+660
| +2% | +$19.3K | 0.45% | 53 |
|
|
2024
Q2 | $959K | Buy |
34,290
+4,515
| +15% | +$124K | 0.44% | 52 |
|
|
2024
Q1 | $826K | Buy |
29,775
+2,875
| +11% | +$79.8K | 0.39% | 54 |
|
|
2023
Q4 | $774K | Sell |
26,900
-6,470
| -19% | -$196K | 0.4% | 53 |
|
|
2023
Q3 | $1.11M | Buy |
33,370
+4,974
| +18% | +$176K | 0.63% | 47 |
|
|
2023
Q2 | $1.04M | Buy |
+28,396
| New | +$1.11M | 0.55% | 52 |
|
|
2021
Q3 | – | Sell |
-6,300
| Closed | -$247K | – | 84 |
|
|
2021
Q2 | $247K | Hold |
6,300
| – | – | 0.12% | 77 |
|
|
2021
Q1 | $228K | Buy |
+6,300
| New | +$224K | 0.12% | 77 |
|
|
2018
Q4 | – | Sell |
-5,138
| Closed | -$215K | – | 64 |
|
|
2018
Q3 | $215K | Buy |
+5,138
| New | +$198K | 0.16% | 63 |
|
|
2018
Q2 | – | Sell |
-6,614
| Closed | -$223K | – | 65 |
|
|
2018
Q1 | $223K | Sell |
6,614
-53
| -0.8% | -$1.82K | 0.17% | 66 |
|
|
2017
Q4 | $229K | Sell |
6,667
-527
| -7% | -$18K | 0.16% | 67 |
|
|
2017
Q3 | $244K | Hold |
7,194
| – | – | 0.17% | 66 |
|
|
2017
Q2 | $229K | Sell |
7,194
-1,581
| -18% | -$49.9K | 0.17% | 66 |
|
|
2017
Q1 | $285K | Buy |
8,775
+53
| +0.6% | +$1.67K | 0.21% | 66 |
|
|
2016
Q4 | $269K | Hold |
8,722
| – | – | 0.2% | 66 |
|
|
2016
Q3 | $280K | Hold |
8,722
| – | – | 0.21% | 68 |
|
|
2016
Q2 | $291K | Sell |
8,722
-1,475
| -14% | -$47.1K | 0.22% | 68 |
|
|
2016
Q1 | $287K | Sell |
10,197
-305
| -3% | -$8.71K | 0.22% | 69 |
|
|
2015
Q4 | $322K | Hold |
10,502
| – | – | 0.25% | 70 |
|
|
2015
Q3 | $313K | Hold |
10,502
| – | – | 0.25% | 73 |
|
|
2015
Q2 | $334K | Hold |
10,502
| – | – | 0.25% | 74 |
|
|
2015
Q1 | $347K | Hold |
10,502
| – | – | 0.25% | 75 |
|
|
2014
Q4 | $310K | Hold |
10,502
| – | – | 0.2% | 78 |
|
|
2014
Q3 | $295K | Hold |
10,502
| – | – | 0.2% | 75 |
|
|
2014
Q2 | $296K | Hold |
10,502
| – | – | 0.19% | 76 |
|
|
2014
Q1 | $320K | Hold |
10,502
| – | – | 0.21% | 74 |
|
|
2013
Q4 | $305K | Hold |
10,502
| – | – | 0.2% | 72 |
|
|
2013
Q3 | $286K | Hold |
10,502
| – | – | 0.2% | 77 |
|
|
2013
Q2 | $279K | Buy |
+10,502
| New | +$290K | 0.2% | 77 |
|
Other funds holding PFE
AIM
CWP
DADC
WG
Harbour Investment Management's PFE Position: Q2 2026 in Review
Harbour Investment Management reduced its Pfizer (PFE) stake by 2% in Q2 2026, selling an estimated $11.8K and leaving 22,010 shares worth $530K. The position accounts for 0.27% of the portfolio, ranked #78.
Harbour Investment Management first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.11M in Q3 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Harbour Investment Management held 22,010 shares of Pfizer worth $530K as of Q2 2026.
- Harbour Investment Management sold 450 Pfizer shares in Q2 2026, an estimated $11.8K.
- Pfizer made up 0.27% of Harbour Investment Management's portfolio in Q2 2026, its #78 holding.
- Harbour Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- Harbour Investment Management's Pfizer position peaked at $1.11M in Q3 2023.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Harbour Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.